Advertisement
Screener

QUIDELORTHO CORP (QDEL) Decrease in Unrecognized Tax Benefits is Reasonably Possible

2.8 / 5 stars · 68/120 Roast Me

QUIDELORTHO CORP Decrease in Unrecognized Tax Benefits is Reasonably Possible

QUIDELORTHO CORP (QDEL) had Decrease in Unrecognized Tax Benefits is Reasonably Possible of $3.20 million as of 2025-09-28, per its 10-Q filed 2025-11-06.

Financial Statements › Notes › Income Taxes › Income Tax Uncertainties

us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible · last filed 2025-11-06

  • 2025-09-28: Decrease in Unrecognized Tax Benefits is Reasonably Possible $3.20M.
  • 2025-06-29: Decrease in Unrecognized Tax Benefits is Reasonably Possible $5.10M.
  • 2025-03-30: Decrease in Unrecognized Tax Benefits is Reasonably Possible $5.10M.
  • 2024-12-29: Decrease in Unrecognized Tax Benefits is Reasonably Possible $5.10M.
Period endDecrease in Unrecognized Tax Benefits is Reasonably Possible
2025-09-28$3.20M
10-Q · filed 2025-11-06
2025-06-29$5.10M
10-Q · filed 2025-08-06
2025-03-30$5.10M
10-Q · filed 2025-05-08
2024-12-29$5.10M
10-K · filed 2025-02-27
2024-09-29$11.70M
10-Q · filed 2024-11-08
2024-06-30$11.70M
10-Q · filed 2024-08-01
2024-03-31$11.90M
10-Q · filed 2024-05-09
2023-12-31$11.70M
10-K/A · filed 2024-08-01
2023-10-01$14.20M
10-Q · filed 2023-11-02
2023-07-02$14.30M
10-Q · filed 2023-08-09
2023-04-02$2.00M
10-Q · filed 2023-05-04
2023-01-01$2.40M
10-K · filed 2023-02-23
2022-10-02$3.00M
10-Q · filed 2022-11-04
2022-07-03$3.00M
10-Q · filed 2022-08-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B
Q/C TECHNOLOGIES, INC. (QCLS)United States$0.008B-1.93
Cardio Diagnostics Holdings, Inc. (CDIO)United States$0.006B
VOLITIONRX LTD (VNRX)$0.003B-0.64
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92